The immunohistochemical reaction to oncostatin M (OSM) was studied in normal human testes at different ages (fetuses, newborns, children, pubertal boys, adults, and elderly men), as well as in several testicular disorders including carcinoma-in-situ cells (CIS), germ cell tumors, benign functioning Leydig cell tumor, androgen insensitivity syndrome, Klinefelter's syndrome, and cryptorchidism. Positive OSM immunostained Sertoli cells were only observed in fetuses. In normal testes, intense OSM immunoreaction was found in the Leydig cells of fetuses, newborns, and adults. Leydig cell immunoreaction was weak in elderly men and absent in children and pubertal boys. In some testicular disorders (Leydig cell tumor, cryptorchidism, and CIS), Leydig cell immunoreaction was as intense as in normal adult testes. This immunoreaction was heterogeneous in androgen insensitivity syndrome and was absent in Klinefelter's syndrome and intratubular seminoma. No recognizable Leydig cells were observed in the other testicular tumors. The findings of our study suggest that, in humans, the down-regulation of OSM immunoexpression in Sertoli cells occurs early, and that OSM immunoreaction in the Leydig cells is associated with functionally active and differentiated Leydig cells. (J Clin Endocrinol Metab 84: 768 -774, 1999) 
N ORMAL testicular maturation involves different
mechanisms that control both the spermatogenic process itself and the development of secondary sexual characteristics. These two functions are under hormonal control by gonadotropins, and in addition, there is a more subtle, local regulation by several growth factors (1) . Among these factors, the interleukin-6 (IL-6) growth factor family seems to play an important role in this paracrine regulation (2) . This IL-6 family includes oncostatin M (OSM), leukemia inhibitory factor (LIF), ciliary neurotropic factor (CNTF), cardiotrophin 1 (CT-1), interleukin 11 (IL-11), and probably granulocyte-colony stimulating factor (G-CSF) (3) . The receptor complexes of all these factors share at least a common subunit, named gp130, which acts as a signal transducer (reviewed in ref. 4) .
OSM was initially characterized by its ability to inhibit growth of several tumor cell lines (5) . Later, it was shown that OSM could also modify the functions of normal tissues (6) . In the testis, the role OSM has been demonstrated in Sertoli cells of neonatal rats (7) . In mouse testicular cell cultures, it has been reported that OSM stimulates both the proliferation of primordial germ cells (PGCs) in fetal testes (8) and, later, the start of spermatogenesis, in postnatal testes (7) . In addition this cytokine has also been found in rat Leydig cells at all ages studied (7) .
As it has been hypothesized that both PGCs and gonocytes are the precursor cells of several germ cell tumors (seminoma and carcinoma in situ, respectively), we investigated the presence of OSM in the Sertoli cells of germ cell tumors. In addition, the observation of OSM expression in rat Leydig cells, even when gonadotropins were low, prompted us to investigate this expression in human testicular disorders showing different types of Leydig cell alterations. Because no previous studies on OSM in human testes had been reported, our study included normal human testes at different ages.
Materials and Methods
Human testicular biopsies and hormonal data were obtained from adult men who consulted at La Paz Hospital (Madrid, Spain) owing to suspicion of testicular tumor or infertility, and who presented the following testicular disorders: carcinoma-in-situ cells (CIS); pure or mixed germ cell tumors including seminoma, teratoma, embryonal carcinoma, and yolk sac tumor; benign functioning Leydig cell tumor; androgen insensitivity syndrome (testicular feminization syndrome); Klinefelter's; and cryptorchidism. Normal testicular biopsies were obtained at autopsy from fetuses (spontaneous abortions), newborns, children, pubertal boys, adults, and elderly men. All these males died from causes other than testicular, endocrine, or related diseases. Adult men selected presented complete spermatogenesis in both testes. The specimens were collected between 6 and 10 h after death. To evaluate postmortem changes in the autopsy specimens, three testes obtained from young men who consulted because of infertility and whose biopsies showed complete spermatogenesis were used for comparison. These men had consulted owing to infertility, and the diagnosis was obstructive azoospermia, localized in the ejaculatory ducts. They were selected after confirming the normality of the bilateral testicular biopsy and hormonal levels and normal spermiogram after treatment (transurethral resection). This investigation was approved by the ethical committee of La Paz Hospital. The number of patients included in each group, their ages, and the number of testes studied are indicated in Table 1 .
The tissue specimens taken from the testes studied were fixed in either Bouin's fixative or 10% formaldehyde in phosphate buffered saline pH 7.4, then embedded in paraffin. Of each testis, five 6-m thick sections were incubated with rabbit antihuman oncostatin M (Santa Cruz Biotechnology, Inc., CA; 0.75 g/mL) for a period of 2 h, at room temperature. Two sections were incubated with normal rabbit serum at the same Ig concentration (negative controls). As an additional negative control, another two sections were incubated with the OSM antibody, to which a 10-fold concentration of the OSM control peptide (Santa Cruz) was added. The nine sections were then rinsed in tris buffered saline (TBS) and incubated with goat antirabbit biotinylated antibody (Vectastain Elite kit, Vector Laboratories, Inc., Burlingame, CA; 1:100 dilution). After rinsing, they were incubated in ABC complex (Vector Laboratories, Inc., diluted 1:500), and the reaction was visualized with diaminobenzidine (Sigma Chemical Co., St. Louis, MO). Then sections were counterstained with Mayer's hematoxylin for 2 min, dehydrated, then mounted in Entellán (Merk, Darmstad, Germany).
Because rat testes show positive immunostaining to the same antibody used here in the Sertoli cells (fetal and newborn testes) and Leydig cells (all ages) (7), sections of fetal (18 days postcoitum), newborn, and adult rat testes were immunostained as the human sections and used as positive controls.
Because a large number of Leydig cells displayed positive immunostaining in some of the testes studied, a semiquantitative evaluation was carried out. For each testis, the percentage of immunostained Leydig cells was calculated by counting at least 50 Leydig cells per section. From the average values for each testis, the mean and standard deviation (sd) for the testis group was obtained. Although most Leydig cells were easily distinguished from other interstitial cells by their round nucleus and ovoid cytoplasm, in order to get a more accurate identification of these cells, two additional sections from each testis were immunostained with testosterone, according to the method described by Nistal et al. (9 -11) .
Results
With the exception of fetal testes, in all testes studied, OSM immunoreaction was observed only in the testicular interstitium, although there were differences in OSM immunoexpression among normal testes, testes with testicular tumors, and testes with nontumoral pathology. The percentage of immunostained Leydig cells in each testis group is shown in Table 1 . With the exception of the androgen insensitivity syndrome, within each testis group the immunostaining pattern was very similar in all testes.
Normal testes
Fetal testes showed seminiferous tubules that were lacking lumen and comprised of Sertoli cells, gonocytes, and fetal spermatogonia. The interstitium was abundant and contained large Leydig cell clusters and numerous blood vessels. An intense immunoreaction to OSM was detected in most Sertoli cells and Leydig cells (Fig. 1, A 
and B).
Newborn testes showed seminiferous tubules with Sertoli cells and spermatogonia. Gonocytes were occasionally observed. The testicular interstitium possessed numerous ovoid or polygonal fetal Leydig cells and spindle-shaped, mesenchymal-like cells. OSM immunoreaction was intense in the cytoplasm of many fetal Leydig cells (Fig. 1C) .
Child testes presented a histologic pattern similar to that of newborn testes, although fetal Leydig cells had disappeared. No OSM immunoreaction was detected (Fig. 1D ).
All pubertal testes showed spermatogenetic development to spermatocytes in most seminiferous tubules and even spermatids in some tubules. Complete spermatogenesis was never observed. Leydig cells were present in varying numbers. Immunoreaction to OSM was only occasionally observed (in less than 2% of Leydig cells) with independence of the spermatogenetic development of tubules (Fig. 1E) .
Adult testes presented complete spermatogenesis in most tubules, and Leydig cell clusters were scattered among the tubules. Most of the Leydig cells exhibited OSM immunoreaction in their cytoplasm (Fig. 1, F and G) . Comparison of the normal adult testes obtained during surgery with the autopsy specimens showed neither histological nor histochemical changes.
Aging testes showed smaller tubules than those of adult testes, and a variable degree of spermatogenetic development: from tubules with only Sertoli cells and spermatogonia to tubules with complete spermatogenesis. The predominant patterns were complete spermatogenesis in one subject testis, germ cell development to spermatocytes and round spermatids in 6 testes, and tubules with Sertoli cells and spermatogonia in one testis. OSM immunoreaction was observed in the Leydig cells, even in testes with marked germ cell depletion, although immunolabeling was weaker than in adult testes in all cases (Fig. 1H) .
Nontumoral disorders
Cryptorchid testes showed a variable testicular pattern: three testes showed Sertoli-cell-only tubules; in six testes the seminiferous tubules contained Sertoli cells and spermatogonia; and the remaining two testes presented germ cell development up to primary spermatocytes and scanty round spermatids. In all cases, the Leydig cells formed clusters as well as large nodules. Most Leydig cells appeared immunostained to OSM, even in the hyperplastic nodules (Fig. 2A) .
The testes of the five patients with Klinefelter's syndrome presented seminiferous tubules with an important degree of sclerosis. Partially sclerosed tubules contained either Sertoli cells only or Sertoli cells and spermatogonia. Leydig cell hyperplasia was a constant finding. No OSM immunoreaction was observed in any testis (Fig. 2B) .
The testes of men with androgen insensitivity syndrome presented a diffuse lesion consisting of small seminiferous tubules, which were devoid of apparent lumen and which contained Sertoli cells and isolated spermatogonia (2 testes) or Sertoli cells only (3 testes). Groups of tubules were separated by wide spaces filled by a fibrous, storiform connective tissue that contained large Leydig cell clusters. In two specimens with Sertoli-cell-only tubules, the testes contained nodules (hamartomas) that stood out from the surrounding testicular parenchyma and consisted of very small seminiferous tubules with immature Sertoli cells and hyalinized lamina propria. Numerous Leydig cells were found among the tubules in all cases. OSM labeling in Leydig cells was observed in three subjects (two with Sertoli-cell-only tubules and one with spermatogonia). However, the distribution of labeling varied widely, from intense to absent, within the same testis and with independence of the lesion zone (diffuse lesion or hamartomatous nodule) and the tubular pattern (Sertoli-cell-only tubules or tubules with spermatogonia) (Fig. 2, C and D) .
Tumors
Leydig cells in testes with CIS cells showed a normal (as in adults) OSM immunoreaction (Fig. 2E) . In the testicular germ cell tumors studied here, the Leydig cells in the testicular parenchyma that surrounded the neoplastic cells immunostained to OSM in a manner similar to that of normal testes, with independence of the degree of spermatogenesis alteration. Within the testicular tumor, no Leydig cells were usually identifiable. However, in testes with intratubular seminoma, the recognizable Leydig cells in the testicular interstitium that was not infiltrated by neoplastic cells, showed no OSM immunoreaction (Fig. 2F) .
In the Leydig cell tumors, neoplastic cells showed a strong reaction to OSM (Fig. 2G) .
Discussion
Comparison of immunostained sections with control sections revealed that, in the human testis, the fetal Sertoli cells and the fetal and adult Leydig cells immunoreact to OSM. However, the semiquantitative study revealed that, when a cell type appeared immunostained, the percentage of immunostained cells was never higher than 80% and usually lower. The possible causes might be: 1) technical limitations causing loss of antigens during procedures; 2) the cytoplasmic portion that contains the antigen was not included in the section thickness; and 3) the antigen is not uniformly expressed by all the cells. This would be related to the functional activity of each single cell. The latter hypothesis would help to explain the less marked, or even absent, immunostaining in some testicular disorders, and it suggests that a loss in oncostatin production is also associated with these disorders.
In the rat testis, OSM was immunodetected in the Sertoli cells from the fetal period to the development of B spermatogonia-that is, at the onset of spermatogenetic development (7). We have detected positive OSM immunostaining in human Sertoli cells exclusively in the fetal testis. If the results obtained in rats were transposable to the human testis, the Sertoli cells of newborns and those of infants younger than 4 yr of age should show OSM immunoreaction, because B spermatogonia does not appear before 4 yr of age (12) . This suggests that, in the human testis, another member of the IL-6 family could be involved in the initiation of the spermatogenetic process. In fact, IL-6 has been shown to be produced by human Sertoli cells (13) .
We have studied OSM immunoreaction in germ cell tumors in order to ascertain whether the formation of these neoplastic cells was associated with a putative re-expression of OSM by the Sertoli cells. However, we failed to find immunostained Sertoli cells in the well-preserved areas of the testicular parenchyma.
In the newborn testis, like in the rat testis (7), both fetal and adult Leydig cells showed immunoreaction to OSM. In the present study, no OSM immunoreaction was observed in infantile testes. The so-called infantile Leydig cells, which populate the testicular interstitium during childhood, display an intermediate ultrastructural pattern between mesenchymal and true Leydig cells and are weakly immunoreactive to testosterone (9) . It has been proposed that these cells could be an involutive stage from fetal Leydig cells, which would undergo dedifferentiation (9, 10). Because proliferation and maintenance of Leydig cell differentiation is modulated by LH and growth factors (14) , it is possible that OSM could be one of those growth factors and that its absence is associated with the loss of Leydig cell differentiation. In addition, it is also possible that in infancy the OSM signal in Leydig cells is substituted by another family member, such as LIF, as demonstrated in rodent testes (15) , or IL-6. IL-6 production by Leydig cells has been reported in rats (16) and humans (13) .
In pubertal boys whose testes have not yet reached complete spermatogenesis, a number of well-differentiated, testosterone-positive Leydig cells have been demonstrated (9) . In the present study, none of the pubertal testes showing these characteristics were positively immunostained to OSM. These results suggest that histochemically detectable Leydig cell production of OSM is only performed by well-differentiated and functionally active Leydig cells. This hypothesis is also sustained by the decrease in OSM reactiveness (from 64% to 37%) in the senile testis, in which Leydig cells undergo a certain dedifferentiation with diminution of the steroidogenic function (17) .
The occurrence of morphological and functional alterations of Leydig cells in cryptorchid testes is controversial. Ultrastructural alterations have been reported (18) , and it has also been documented that human cryptorchidism is sometimes associated with anomalies in the hypothalamic-pituitary-gonadal axis, which would lead to alterations in Leydig cells (19) . In contrast, Mancini et al. (20) failed to find morphological differences between the Leydig cells of human cryptorchid testes and those of normal testes. Present results suggest a normal Leydig cell differentiation in cryptorchid testes because OSM expression in these Leydig cells-even in areas where Leydig cell hyperplasia was observed-was similar to that of normal adult testes.
In Klinefelter's syndrome, in addition to morphologically normal Leydig cells, altered Leydig cells have been reported (17) and the number of testosterone-positive Leydig cells has found to be decreased (11) . The absence of OSM suggests a nonfunctional state of the Leydig cells in these patients. Endocrinological studies revealed that androgens levels are under half of the normal values (21) .
The histologic testicular pattern in the cases of androgen insensitivity syndrome studied here fits with previous studies (22) . OSM immunostaining revealed intensely stained Leydig cells together with unstained Leydig cells in some patients and complete absence of immunostaining in other patients. This agrees with previous descriptions of varying numbers of morphologically altered Leydig cells in this syndrome (23) and important alterations in the regulation of the hypothalamic-hypophyseal-testicular axis (24) . In this syndrome, estrogen production has been found to be increased 2-fold, and this has been attributed to an increased stimulation of Leydig cells by LH (25) , whereas testosterone values remain normal or slightly elevated (24) .
Functioning testicular Leydig cell tumors secreted active steroids, resulting in increased estradiol and normal-to-low testosterone values in peripheral blood, although LH levels were low (26) . Ultrastructural studies on Leydig cell tumors revealed a decreased amount of smooth endoplasmic reticulum, although all other cytologic features were typical of normal Leydig cells (27) . The presence of OSM in these cells, as in the adult normal testes, corroborated the idea that neoplastic Leydig cells did not undergo dedifferentiation and are functionally active.
It has been proposed that CIS cells give rise to seminoma (28) and, thereafter, to other types of germ cell tumors (48). The presence of androgen receptors in CIS and seminoma cells suggests an involvement of Leydig cells in the development of testicular germ cell tumors (29) . Because the Leydig cells among tubules with CIS cells showed normal OSM immnoexpression, whereas those in intratubular seminoma did not immunostain, it was tempting to speculate that OSM might be indirectly (through Leydig cells) involved in such tumor development and that OSM expression in Leydig cells was lost during this progression. In other tumor progressions, breast cancer for instance, OSM, IL-6, and LIF have stimulated the activity of 17␤-HSD (30) .
A gradient effect has been described in the impairment of spermatogenesis near malignant neoplasms, suggesting a direct factor-mediated influence of tumor on spermatogenesis (31) . Interestingly, OSM has been shown to inhibit the growth of a variety of solid tumors (6) and, together with LIF and IL-6, to induce the differentiation of myeloid leukemia cells (32) . The presence of specific receptors for these factors in testicular tumors would give more information about the possible implication of this family of growth factors in testicular tumorigenesis.
In conclusion, OSM expression in the human testis does not match that of rodents, as it is not present in the human Sertoli cells at the onset of spermatogenesis and because a down-regulation does take place in the human infantile Leydig cells. The presence of this protein in the Leydig cells of newborn and adult normal testes suggests a role in the maintenance of Leydig cell differentiation. In general, the appearance of OSM in these cells coincides with those Leydig cells that are functionally active and well differentiated.
